← Back to headlines





The Decline of BioNTech, the Pandemic's Vaccine Hero
A report on how BioNTech, the German pharmaceutical company that developed the first approved mRNA COVID-19 vaccine, has seen its fortunes decline six years after its pandemic peak.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories

Revolut Secures Conditional Approval for US National Bank Charter
22m ago

Volkswagen Supervisory Board Approves Comprehensive Restructuring Plan
23m ago
Microsoft Introduces Monthly Hour Limits for Xbox Cloud Gaming
52m ago

Ryanair Cuts Winter Flight Capacity and Warns of Fare Increases Amid High Fuel Costs
1h ago